Contributors |
|
xi | |
Preface |
|
xv | |
Reviewers |
|
xvii | |
I Background of the Laboratory Rat |
|
|
|
|
|
|
|
3 | (1) |
|
II Origins of the Laboratory Rat |
|
|
3 | (1) |
|
III The Wistar Institute and the Development of Rats in Research |
|
|
4 | (8) |
|
IV Neuroscience and Behavioral Research |
|
|
12 | (2) |
|
V Nutrition and Biochemistry |
|
|
14 | (5) |
|
VI Endocrinology and Reproductive Physiology |
|
|
19 | (2) |
|
|
21 | (4) |
|
VIII Cancer Research Institutes |
|
|
25 | (4) |
|
IX Gnotobiology: Rats Without Microflora |
|
|
29 | (5) |
|
X Genealogy of Major Rat Stocks and Strains |
|
|
34 | (3) |
|
XI Genetic Repositories and Standards |
|
|
37 | (1) |
|
XII Securing Healthy Foundations |
|
|
37 | (3) |
|
XIII The Role of the National Institutes of Health |
|
|
40 | (1) |
|
XIV Information Dissemination and Exchange |
|
|
40 | (1) |
|
|
41 | (1) |
|
|
41 | (5) |
|
|
46 | (1) |
|
2 Taxonomy and Stocks and Strains |
|
|
|
|
|
47 | (1) |
|
II Taxonomy and Geographical Distribution |
|
|
47 | (4) |
|
III Adaptation to the Laboratory |
|
|
51 | (1) |
|
IV Stocks and Strains of Laboratory Rats |
|
|
52 | (18) |
|
|
70 | (2) |
|
|
72 | (1) |
|
|
72 | (5) |
|
3 Translational Potential of Rats in Research |
|
|
|
|
|
|
77 | (1) |
|
II Benefits of Rat Models |
|
|
77 | (2) |
|
III Genomic Advances in the Rat |
|
|
79 | (3) |
|
IV Translational Success and Ongoing Advancements Using Rat Models |
|
|
82 | (1) |
|
|
83 | (1) |
|
|
83 | (8) |
II Biology and Care |
|
|
4 Functional Anatomy and Physiology |
|
|
|
|
|
|
|
|
91 | (1) |
|
|
91 | (11) |
|
|
102 | (4) |
|
|
106 | (3) |
|
|
109 | (3) |
|
VI Urinary and Reproductive Systems |
|
|
112 | (5) |
|
|
117 | (2) |
|
|
119 | (3) |
|
|
122 | (1) |
|
|
122 | (11) |
|
5 Clinical Pathology of the Rat |
|
|
|
|
|
|
133 | (1) |
|
II Considerations of Blood and Urine Collection and Sample Handling |
|
|
134 | (2) |
|
III Use of Reference Intervals in Data Interpretation |
|
|
136 | (1) |
|
IV Hematology, Clinical Chemistry, Urinalysis, and Coagulation |
|
|
137 | (2) |
|
V Interpretation of Disease States in the Rat |
|
|
139 | (10) |
|
|
149 | (1) |
|
|
149 | (1) |
|
|
149 | (6) |
|
|
155 | (2) |
|
6 Reproduction and Breeding |
|
|
|
|
|
|
|
157 | (1) |
|
|
157 | (7) |
|
III Factors Affecting Breeding Performance |
|
|
164 | (4) |
|
|
168 | (7) |
|
|
175 | (6) |
|
7 Assisted Reproductive Technologies and Genetic Modifications in Rats |
|
|
|
|
|
181 | (1) |
|
II Assisted Reproductive Technologies |
|
|
182 | (9) |
|
|
191 | (3) |
|
|
194 | (12) |
|
|
206 | (1) |
|
|
207 | (1) |
|
|
207 | (8) |
|
8 Analysis of Behavior in Laboratory Rats |
|
|
|
|
|
|
215 | (1) |
|
II General Methodological Approaches |
|
|
216 | (2) |
|
III The Neurobehavioral Examination |
|
|
218 | (2) |
|
|
220 | (2) |
|
V Immobility and Associated Reflexes |
|
|
222 | (2) |
|
|
224 | (3) |
|
|
227 | (2) |
|
VIII Species-Typical Behaviors |
|
|
229 | (5) |
|
|
234 | (3) |
|
X Comments on Generalizing From Behavioral Analysis |
|
|
237 | (1) |
|
|
238 | (4) |
|
|
242 | (1) |
|
|
|
|
|
|
|
|
243 | (1) |
|
|
243 | (49) |
|
III Naturally Occurring Contaminants |
|
|
292 | (5) |
|
IV Regulation of Food and Fluid Intake |
|
|
297 | (5) |
|
V Considerations for Dosing via Diet |
|
|
302 | (1) |
|
VI Diet-Induced Models of Disease |
|
|
303 | (2) |
|
VII Classification and Selection of Diets |
|
|
305 | (3) |
|
|
308 | (1) |
|
|
309 | (1) |
|
X Physical Forms of Rat Diets |
|
|
310 | (1) |
|
|
310 | (4) |
|
XII Diet Storage and Shelf Life |
|
|
314 | (1) |
|
|
315 | (1) |
|
|
315 | (34) |
|
10 Housing and Environment |
|
|
|
|
|
|
|
349 | (1) |
|
|
350 | (13) |
|
III Environmental Factors |
|
|
363 | (18) |
|
IV Feed, Water, and Bedding |
|
|
381 | (4) |
|
V Chemical Factors in the Environment |
|
|
385 | (6) |
|
VI Miscellaneous Environmental Factors |
|
|
391 | (6) |
|
|
397 | (1) |
|
|
397 | (20) |
|
|
417 | (4) |
III Clinical Care and Disease |
|
|
11 Medical Management and Diagnostic Approaches |
|
|
|
|
|
|
421 | (1) |
|
II Individual Animal Monitoring and Care |
|
|
421 | (1) |
|
III Colony Health Management |
|
|
422 | (7) |
|
|
429 | (17) |
|
V Management of Colony Disease Outbreaks |
|
|
446 | (1) |
|
|
447 | (1) |
|
|
447 | (4) |
|
12 Bacterial, Mycoplasmal, and Mycotic Infections |
|
|
|
|
|
|
451 | (5) |
|
|
456 | (41) |
|
III Mycoplasmal Infections |
|
|
497 | (6) |
|
|
503 | (9) |
|
|
512 | (26) |
|
|
538 | (3) |
|
|
|
|
|
|
541 | (1) |
|
|
541 | (8) |
|
|
549 | (11) |
|
|
560 | (1) |
|
|
560 | (1) |
|
|
560 | (9) |
|
|
|
|
|
|
569 | (1) |
|
II Parasites of Parenteral Systems |
|
|
570 | (9) |
|
III Parasites of the Alimentary System |
|
|
579 | (9) |
|
IV Parasites of the Integument |
|
|
588 | (3) |
|
|
591 | (1) |
|
|
592 | (1) |
|
|
593 | (6) |
|
|
599 | (2) |
|
|
|
|
Kyathanahalli S. Janardhan |
|
|
|
|
601 | (2) |
|
II The Rat as an Experimental Model in Oncology |
|
|
603 | (1) |
|
|
603 | (9) |
|
IV Musculoskeletal System |
|
|
612 | (2) |
|
|
614 | (3) |
|
|
617 | (1) |
|
|
618 | (7) |
|
|
625 | (5) |
|
IX Hematopoietic and Lymphatic System |
|
|
630 | (1) |
|
|
631 | (2) |
|
XI Female Reproductive System |
|
|
633 | (3) |
|
|
636 | (1) |
|
XIII Male Reproductive System |
|
|
637 | (2) |
|
|
639 | (3) |
|
|
642 | (1) |
|
|
642 | (9) |
|
16 Metabolic, Traumatic, and Miscellaneous Diseases |
|
|
|
|
|
|
651 | (2) |
|
|
653 | (6) |
|
|
659 | (1) |
|
|
659 | (3) |
|
V Gastrointestinal System |
|
|
662 | (4) |
|
|
666 | (8) |
|
|
674 | (1) |
|
|
675 | (1) |
|
|
676 | (4) |
|
|
680 | (1) |
|
|
681 | (2) |
|
|
683 | (1) |
|
|
684 | (1) |
|
|
684 | (15) |
|
17 Anesthesia, Analgesia, and Euthanasia |
|
|
|
|
|
|
|
699 | (1) |
|
II Preoperative Considerations |
|
|
699 | (3) |
|
III Drug Doses and Dose Preparation |
|
|
702 | (3) |
|
IV Administration Routes and Equipment |
|
|
705 | (5) |
|
|
710 | (2) |
|
VI Parenteral Anesthetics |
|
|
712 | (7) |
|
VII Special Anesthetic Considerations |
|
|
719 | (1) |
|
VIII Pain Assessment and Treatment |
|
|
720 | (9) |
|
|
729 | (6) |
|
|
735 | (1) |
|
|
735 | (10) |
|
|
745 | (2) |
|
18 Care of Surgical and Other Fragile Models |
|
|
|
|
|
|
747 | (1) |
|
II Surgical Considerations |
|
|
747 | (8) |
|
III Pain Assessment and Treatment |
|
|
755 | (2) |
|
IV Surgical and Other Fragile Models |
|
|
757 | (7) |
|
|
764 | (7) |
IV Rats as Research Models |
|
|
19 General Experimental Techniques |
|
|
|
|
|
|
|
771 | (1) |
|
II Handling and Restraint |
|
|
771 | (3) |
|
III Identification Methods |
|
|
774 | (2) |
|
|
776 | (21) |
|
V Specialized Research Techniques |
|
|
797 | (3) |
|
|
800 | (1) |
|
|
800 | (11) |
|
20 Integrating Biology With Rat Genomic Tools |
|
|
|
|
|
I Background to the Rat Genome and Tools |
|
|
811 | (1) |
|
II Rat Genome Assembly and Mapping Update |
|
|
812 | (2) |
|
III Gene Expression and Functional Annotation |
|
|
814 | (1) |
|
|
815 | (1) |
|
|
816 | (2) |
|
VI Rat Genetic and Genomic Data |
|
|
818 | (2) |
|
|
820 | (1) |
|
|
820 | (1) |
|
|
821 | (1) |
|
|
821 | (6) |
|
21 Gnotobiotics and the Microbiome |
|
|
|
|
|
|
|
827 | (1) |
|
|
827 | (4) |
|
II The Germfree and Defined Flora Laboratory Rat |
|
|
831 | (7) |
|
III Research Applications of Gnotobiotic Rats |
|
|
838 | (3) |
|
|
841 | (1) |
|
|
842 | (1) |
|
|
843 | (1) |
|
|
843 | (6) |
|
|
|
|
|
|
849 | (1) |
|
|
849 | (1) |
|
III Use of the Rat in Pharmacologic Testing: An Overview |
|
|
850 | (1) |
|
|
851 | (5) |
|
V Consideration of Variables in Toxicological Testing |
|
|
856 | (3) |
|
|
859 | (1) |
|
|
859 | (1) |
|
|
859 | (1) |
|
|
860 | (2) |
|
|
862 | (1) |
|
23 Embryology and Teratology |
|
|
|
|
|
|
863 | (1) |
|
|
863 | (14) |
|
III Experimental Teratology |
|
|
877 | (8) |
|
|
885 | (1) |
|
|
885 | (6) |
|
|
|
|
|
|
891 | (1) |
|
II Overview of the Rat's Immune System |
|
|
892 | (10) |
|
III Rats as Animal Models in Immunology Research |
|
|
902 | (11) |
|
IV Summary and Conclusions |
|
|
913 | (1) |
|
|
913 | (1) |
|
|
913 | (14) |
|
25 Cardiovascular Research |
|
|
|
|
|
|
|
|
|
|
927 | (1) |
|
|
927 | (4) |
|
|
931 | (3) |
|
IV Methods for in Vivo Evaluation of the Cardiovascular System |
|
|
934 | (3) |
|
V Methods for in Vitro Study of Myocardium |
|
|
937 | (2) |
|
VI Genetic Models of Human Cardiovascular Disease |
|
|
939 | (5) |
|
VII Transgenic Rat Models of Human Heart Disease |
|
|
944 | (1) |
|
VIII Experimentally Induced Models for Cardiovascular Research |
|
|
945 | (6) |
|
IX Use of the Rat for Miscellaneous Studies |
|
|
951 | (2) |
|
X Special Considerations for Use of the Rat in Cardiovascular Research |
|
|
953 | (1) |
|
|
954 | (1) |
|
|
954 | (1) |
|
|
954 | (13) |
|
26 Rat Models of Alcohol Use Disorder |
|
|
|
|
|
Krystal Allen-Worthington |
|
|
|
967 | (3) |
|
II History of the Use of Rats to Model AUD |
|
|
970 | (1) |
|
III Experimenter Administration |
|
|
971 | (2) |
|
IV Methodology and Animal Models of Different Aspects of Alcohol Use Disorders |
|
|
973 | (7) |
|
V Summary and Future Directions |
|
|
980 | (1) |
|
|
981 | (1) |
|
|
981 | (6) |
|
27 Rat Models of Obesity, Metabolic Syndrome, and Diabetes |
|
|
|
Claudio E. Perez-Leighton |
|
|
|
|
|
|
I Introduction: Models of Obesity, Metabolic Syndrome, and Diabetes |
|
|
987 | (1) |
|
|
987 | (3) |
|
III Rat Models of Metabolic Syndrome |
|
|
990 | (2) |
|
|
992 | (6) |
|
|
998 | (1) |
|
|
998 | (5) |
|
28 The Rat in Neuroscience Research |
|
|
|
|
|
|
1003 | (1) |
|
II Models of Mental Illness |
|
|
1003 | (6) |
|
III Neurodegenerative Diseases |
|
|
1009 | (4) |
|
IV Somatic and Visceral Pain |
|
|
1013 | (4) |
|
|
1017 | (1) |
|
|
1017 | (6) |
|
29 Rat Models of Central Nervous System Injury |
|
|
|
|
|
|
|
|
1023 | (1) |
|
|
1023 | (23) |
|
III Traumatic Brain Injury |
|
|
1046 | (13) |
|
|
1059 | (1) |
|
|
1060 | (17) |
|
30 Use of the Rat as a Model in Regenerative Medicine |
|
|
|
|
|
|
|
|
|
|
|
1077 | (1) |
|
|
1078 | (3) |
|
|
1081 | (2) |
|
|
1083 | (6) |
|
|
1089 | (4) |
|
|
1093 | (3) |
|
|
1096 | (1) |
|
|
1097 | (1) |
|
|
1097 | (10) |
|
31 Rat Models of Infectious Disease |
|
|
|
|
|
|
I Introduction: The Rat in Infectious Disease Research |
|
|
1107 | (1) |
|
II Central Nervous System |
|
|
1107 | (4) |
|
|
1111 | (6) |
|
IV Multisystemic Conditions |
|
|
1117 | (5) |
|
V Soft Tissue and Bone: Primary Infections and Biofilms |
|
|
1122 | (2) |
|
|
1124 | (3) |
|
VII Conclusions and Future Approaches: The HIV-1 Tg Rat |
|
|
1127 | (1) |
|
|
1128 | (7) |
Index |
|
1135 | |